GlassScriptPhysician profile
Claire Pearson
NPI 1093324816
$722.76
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $470 · 2024: $39.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $156.06 | 2021-2022 | |
| Astellas Pharma US INC | $126.49 | 2022 | |
| Convatec INC. | $55.49 | 2021-2024 | |
| Ucb, INC. | $53.11 | 2021-2022 | |
| 180 Medical, INC. | $52.12 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $44.41 | 2021-2022 | |
| Olympus America INC. | $38.66 | 2021-2022 | |
| Biogen, INC. | $36.02 | 2021-2022 | |
| Rochester Medical Corporation | $24.00 | 2022 | |
| Neurocrine Biosciences, INC. | $23.14 | 2024 | Ingrezza |
| Abbvie INC. | $19.01 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.66 | 2022 | |
| Endo Pharmaceuticals INC. | $14.85 | 2021 | |
| Neurelis, INC. | $14.80 | 2022 | |
| Abbott Laboratories | $13.37 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $11.89 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.45 | 2021 | |
| Ethicon US, LLC | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.